Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 74 results for "sun pharmaceutical industries"

Here#39;s 360 degree view on Sun Pharmaceutical CDSL
Money Control

Pharma stocks on mutual funds' radar post price correction

Domestic mutual funds (MFs) have taken a liking to pharmaceutical stocks, following a steep fall in the latter's prices.While they expect the pharma sector to undergo headwinds, they are taking a contrarian view on select stocks, with an investment horizon of ... Business Standard, 5 days ago

16 images for sun pharmaceutical industries

Sify, 1 month ago
Money Control, 3 weeks ago
Reuters, 1 month ago
Sify, 2 months ago
Money Today, 1 month ago
Sify, 3 months ago
Money Today, 1 month ago
Sify, 2 months ago
Sify, 4 months ago
Reuters, 4 months ago

Sun Pharma advances after settling antitrust litigation in US

Sun Pharmaceutical Industries gained 2.35% to Rs 562.60 at 9:35 IST on BSE after the company said it has entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation matter.
 Business Standard1 week ago Sun Pharma enters into settlement with some complainants in  DNA2 weeks ago

Global Markets End on a Positive Note

Posted by Equitymaster Global financial markets ended the week on a positive note with an upward boost from Brazil, Hong Kong and Indian share markets, which were up 5%, 4.1% and 2.1% respectively. While the US markets ended the week marginally lower by 0.2%, ...
 Equitymaster.com1 week ago Global Markets End on a Mixed Note  Equitymaster.com2 weeks ago

Looking ahead: stocks to beat the odds

Following returns of about 17 per cent from benchmark indices in the first half of 2017, the focus has shifted to the second half of the year. Financial Chronicle spoke to leading brokers and asked them to name their top picks for the second half of 2017 that ...
 The Financial Chronicle1 week ago

Board of Sun Pharmaceuticals Industries recommends final dividend

Of Rs 3.5 per share
 Business Standard1 month ago Sun Pharma down over 11% on disappointing results  Sify1 month ago Sun Pharma tanks after posting dismal Q4 results  Business Standard1 month ago BUZZ-India's Sun Pharma plunges to 3-1/2-yr low; Q4 profit falls 14 pct  Sify1 month ago
Money Control

USFDA approves Sun Pharma's generic ezetimibe tablets

Drug major Sun Pharmaceutical Industries on Tuesday announced that one of its wholly owned subsidiaries has received final approval from the US Food and Drug Administration (USFDA) for its generic version of ezetimibe tablets.According to Sun Pharma, the ...
 Prokerala1 month ago Sun Pharmaceutical gains 3% on USFDA approval for Zetia tablets  Money Control1 month ago Sun Pharmaceutical Industries receives final approval for generic ezetimibe tablets  Business Standard1 month ago Sun Pharma rises after USFDA approval for generic drug  Business Standard1 month ago

Sun Pharma to develop chikungunya, zika drugs

Sun Pharmaceutical Industries has tied up with Pune-based National Institute of Virology to develop new drugs to treat chickungunya, dengue and zika. The partnership is a part of company's plans to develop drugs which cater to unmet needs of patients.
 Business Standard3 weeks ago Sun Pharma, NIV join hands to fight zika, chikungunya, dengue  Business Standard3 weeks ago

Sun Pharma shares hit 52-week low, tank over 13%

Shares of Sun Pharma today crashed by over 13 per cent after the company reported a 14 per cent decline in consolidated net profit for the fourth quarter ended March. The stock plunged 13.28 per cent to Rs 493 -- its 52-week low -- on the BSE. On the NSE, it ...
 Business Standard1 month ago Sun Pharmaceuticals Industries consolidated net profit declines 16.67% in the March 2017 quarter  Business Standard1 month ago Sun Pharmaceuticals Industries standalone net profit rises 84.32% in the March 2017 quarter  Business Standard1 month ago Sun Pharma Q4 dips 14% to Rs 1,223cr on pricing pressure in US  Business Standard1 month ago

FDC drug ban: Delhi HC denies interim relief to pharma companies

[India], June 30 (ANI): The Delhi High Court on Friday denied any interim relief to several pharmaceutical companies over government's ban on Fixed Dose Combination (FDC) drugs. A vacation bench of Justice Manmohan said the court wants to wait till July 11, ...
 Sify3 weeks ago

Delhi HC to hear pharma firms plea on fixed dose drugs ban

The Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that banned certain fixed dose combination (FDC) drugs.In its earlier hearing on June 21, the High Court denied ...
 Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less